Opioids: New Insights

In this episode, Dr. Mohit Bhandari sits down with Dr. Niloofar Dehghan to discuss the newly published JAMA paper titled "Operative vs Nonoperative Treatment of Acute Unstable Chest Wall Injuries." 

In this episode, Dr. Mohit Bhandari sits down with two orthopedic residents, Dr. Aaron Gazendam and Dr. Seper Ekhtiari, to discuss their newly published JAMA paper titled “Effect of a postoperative multimodal opioid-sparing protocol vs standard opioid prescribing on postoperative opioid consumption after knee or shoulder arthroscopy.”

In this episode, Dr. Bhandari is joined in studio by Dr. Gerard Slobogean. They discuss Dr. Slobogean's pathway to success in clinical research  and what it means to "make it" in clinical research. How to achieve success, and how to plan what's next after large clinical trials. 

In this episode, Marc and Mo are joined by special guests Matt Schmitz (JBJS Deputy Editor for Social Media; San Antonio Military Medical Center; Uniformed Services University of the Health Sciences; Brooke Army Medical Center) and Patrick Osborn (Brooke Army Medical Center; Baptist Health System) in a discussion on the research being done by the Major Extremity Trauma and Rehabilitation Consortium (METRC) and how the knowledge gained has impacted the ability of the orthopaedic surgeon to treat the injured warrior.

In this episode, Dr. Mohit Bhandari sits down with Dr. David Beard, to discuss his newly published Lancet paper titled "Rehabilitation versus surgical reconstruction for non-acute anterior cruciate ligament injury (ACL SNNAP)".

In this episode, Dr. Mohit Bhandari sits down with Dr. Jason Busse, to discuss his newly published British Journal of Anesthesia paper titled "Comparative benefits and harms of individual opioids for chronic non-cancer pain: a systematic review and network meta-analysis of randomized trials".  They discuss how the research team examined the comparative effects of individual opioids for chronic non-cancer pain through a network meta-analysis of randomized controlled trials.